Ajanta Pharma Q2 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
2,610.25
21.90 (0.85%)
21.90 (0.85%)Volume1.85 K
Updated: Fri 11 Jul, 2025 | 15:28:00
NSE
2,626.5035.20 (1.36%)
35.20 (1.36%)Volume2.37 L
Updated: Fri 11 Jul, 2025 | 15:41:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 884.21 | 848.54 | 4.20% |
| Depreciation/ Amortization | 34.39 | 33.97 | 1.24% |
| Operating Income | 302.43 | 296.38 | 2.04% |
| Net Income | 216.48 | 245.77 | -11.92% |
| Other Operating Expenses Total | 327.18 | 262.94 | 24.43% |
| Net Income Before Taxes | 290.24 | 322.12 | -9.90% |
| Total Revenue | 1,186.64 | 1,144.92 | 3.64% |
| Selling/ General/ Admin Expenses Total | 260.96 | 283.78 | -8.04% |
| Diluted Normalized EPS | 17.26 | 19.53 | -11.62% |